Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy (2015)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1016/j.ejca.2014.10.019
- Subjects: NEOPLASIAS COLORRETAIS (TERAPIA); FATORES DE CRESCIMENTO; QUIMIOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Cancer
- ISSN: 0959-8049
- Volume/Número/Paginação/Ano: v. 51, n. 1, p. 18-26, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
RUFF, Paul et al. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, v. 51, n. 1, p. 18-26, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2014.10.019. Acesso em: 15 jan. 2026. -
APA
Ruff, P., Ferry, D. R., Lakomỳ, R., McWalter, G., Van Hazel, G. A., Hoff, P. M., et al. (2015). Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, 51( 1), 18-26. doi:10.1016/j.ejca.2014.10.019 -
NLM
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2026 jan. 15 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019 -
Vancouver
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2026 jan. 15 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019 - A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers
- Palliative chemotherapy in patients with malignant bowel obstruction
- Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?
- Is surgery always necessary in rectal cancer?
- Estudo epidemiológico de pacientes com adenocarcinoma colorretal submetidos à ressecção do primário: descrição de 212 pacientes operados no Instituto do Câncer do Estado de São Paulo - ICESP
- Uso de sorafenibe em pacientes com carcinoma hepatocelular (CHC) Child-Pugh B: análise retrospectiva de onze pacientes
- Liga de Oncologia da Faculdade de Medicina da Universidade de São Paulo (FMUSP): experiência de 13 anos
- Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity
- Revisão de processos reduz tempo de implementação de estudos clínicos no Instituto do Câncer do Estado de São Paulo
- Pneumonite induzida por taxanos: relato de três casos e revisão da literatura
Informações sobre o DOI: 10.1016/j.ejca.2014.10.019 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
